The Vanguard Group Discloses Position in Mural Oncology plc

The Vanguard Group, Inc., a major player in asset management, has disclosed its position in Mural Oncology plc, adhering to Rule 8.3 of the Irish Takeover Panel Act. As of October 24, 2025, Vanguard holds interests in 288,827 ordinary shares of $0.01 par value, which represents 1.67% of Mural Oncology's relevant securities. This filing arises in the context of potential takeover activities monitored by the Irish Takeover Panel.

The disclosure statement confirms that Vanguard conducted a sale of 32 ordinary shares at a price of 2.08 USD each. No further positions in cash-settled or stock-settled derivatives were reported. Additionally, no indemnities or agreements influencing these securities were disclosed, suggesting a straightforward holding structure without complex derivative positions or strategic arrangements.